Primary Immunodeficiency Diseases Associated with Neurologic Manifestations

被引:0
作者
Soodabeh Fazeli Dehkordy
Asghar Aghamohammadi
Hans D. Ochs
Nima Rezaei
机构
[1] Tehran University of Medical Sciences,Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center
[2] Tehran University of Medical Sciences,Molecular Immunology Research Center and Department of Immunology, School of Medicine
[3] University of Washington,Department of Pediatrics
[4] Seattle Children’s Research Institute,Department of Infection and Immunity, School of Medicine and Biomedical Sciences
[5] The University of Sheffield,undefined
来源
Journal of Clinical Immunology | 2012年 / 32卷
关键词
Primary immunodeficiency diseases; neurologic manifestations; ataxia-telangiectasia; DNA damage;
D O I
暂无
中图分类号
学科分类号
摘要
Primary immunodeficiency diseases (PID) are a heterogeneous group of inherited disorders of the immune system, predisposing individuals to recurrent infections, allergy, autoimmunity, and malignancies. A considerable number of these conditions have been found to be also associated with neurologic signs and symptoms. These manifestations are considered core features of some immunodeficiency syndromes, such as ataxia-telangiectasia and purine nucleoside phosphorylase deficiency, or occur less prominently in some others. Diverse pathological mechanisms including defective responses to DNA damage, metabolic errors, and autoimmune phenomena have been associated with neurologic abnormalities; however, several issues remain to be elucidated. Greater awareness of these associated features and gaining a better understanding of the contributing mechanisms will lead to prompt diagnosis and treatment and possibly development of novel preventive and therapeutic strategies. In this review, we aim to provide a brief description of the clinical and genetic characteristics of PID associated with neurologic complications.
引用
收藏
页码:1 / 24
页数:23
相关论文
共 1028 条
  • [1] Geha RS(2007)Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee J Allergy Clin Immunol 120 776-94
  • [2] Notarangelo LD(1991)Purine nucleoside phosphorylase deficiency Immunodefic Rev 3 45-81
  • [3] Casanova JL(2008)The neurological phenotype of ataxia-telangiectasia: solving a persistent puzzle DNA Repair (Amst) 7 1028-38
  • [4] Chapel H(2001)A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy Clin Exp Rheumatol 19 103-6
  • [5] Conley ME(2007)Update on the treatment of primary immunodeficiencies Allergol Immunopathol (Madr) 35 184-92
  • [6] Fischer A(1972)Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity Lancet 2 1067-9
  • [7] Markert ML(2009)New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy Curr Opin Allergy Clin Immunol 9 496-502
  • [8] Biton S(2001)Immunodeficiency caused by adenosine deaminase deficiency Immunol Allergy Clin North Am 20 161-75
  • [9] Barzilai A(1997)Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency J Inherit Metab Dis 20 179-85
  • [10] Shiloh Y(2007)Neurologic abnormalities in patients with adenosine deaminase deficiency Pediatr Neurol 37 218-21